Latest Food and Drug Administration Stories
Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The National Plaintiff’s Law Firm of Baron and Budd is now handling lawsuits pertaining to the recall of Granuflo, the brand name of a dialysate (http://www.fda.gov/medicaldevices/safety/listofrecalls/ucm309990.htm ). Dialysate is used when a patient undergoes dialysis, a long-term medical treatment used to treat kidney conditions....
http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today! New York, NY (PRWEB) May 09, 2013 The prescription device safety center at DrugRisks.com is announcing updated information on the site for women using the IUD contraceptive Mirena. Patients are advised that experts have warned of perforation injuries and some have already filed legal claims*. DrugRisks was created to improve the safety of...
The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) May 09, 2013 The prescription drug resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa of updated safety information on the site. The warning label for the drug was recently changed to advise that some people using the medication have reported a blood condition*. The goal of...
The Mirena IUD lawyers at the Rottenstein Law Group are troubled by recent news that the U.S. Food and Drug Administration has to date received more than 47,000 adverse event reports about Mirena side effects for the Bayer-manufactured hormonal contraceptive device.* (PRWEB) May 09, 2013 The Mirena IUD lawyers at the Rottenstein Law Group are troubled by recent news reported in AdverseEvents that the U.S. Food and Drug Administration has to date received more than 47,000 adverse event...
[WATCH VIDEO: Caffeine In Food Investigated By FDA] Michael Harper for redOrbit.com – Your Universe Online For whatever reason, food and drink makers have been actively pursuing ways to put caffeine into otherwise caffeine-free products including Cracker Jacks, potato chips and chewing gum. Wrigley, for instance, recently launched Alert Energy Caffeine Gum which contains 40 milligrams of caffeine — about as much as a half cup of coffee — in each piece. Meanwhile the FDA and...
WARSAW, Indiana, May 9, 2013 /PRNewswire/ -- More than 300 professionals from over 100 unique OEMs and manufacturers have pre-registered to attend this year's conference program, on June 5 - 6, 2013 at Grace College in Warsaw, IN. Employees at major orthopaedic OEMs are eligible for free registration at http://www.orthotecshow.com The Mayor of the City of Warsaw, Dr. Joe Thallemer will introduce Opening Keynote Speakers on both days of the OrthoTec 2013 Conference and...
Emmaus in Process of Completing Phase 3 Study For First Widely Available Treatment for Sickle Cell Disease TORRANCE, Calif., May 9, 2013 /PRNewswire/ -- Timothy Cote, M.D., MPH, former director of the Office of Orphan Product Development of the U.S. Food and Drug Administration, has joined Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, in an advisory capacity, the company announced today. Dr. Cote will advise Emmaus on the regulatory pathway for...
Health & Life Co., LTD. Issues Nationwide Recall of EZ Breathe(TM) Atomizer, Model #EZ-100 NEW TAIPEI CITY, Taiwan, May 8, 2013 /PRNewswire/ -- Recall Managed By: Nephron Pharmaceuticals Corporation Health & Life Co., LTD 9F, No. 186, Jian Yi Road Zhonge District 23553 New Taipei City, Taiwan 886.2.82271300 www.healthandlife.com.tw On May 8, 2013, Health & Life, Co., LTD, initiated a nationwide recall of 242,892 EZ Breathe(TM) Atomizers, Model #EZ-100, after...
SAN DIEGO, May 8, 2013 /PRNewswire/ -- Orexigen(®) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter ended March 31, 2013. For the three months ended March 31, 2013, Orexigen reported a net loss of $19.4 million, or $0.21 per share, as compared to a net loss of $10.4 million, or $0.16 per share, for the first quarter of 2012. Total operating expenses for the first quarter...
WASHINGTON, May 8, 2013 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today applauded Senators Kirsten Gillibrand (D-NY), Dianne Feinstein (D-CA), and Susan Collins (R-ME), for introducing the Antimicrobial Data Collection Act, which would require the U.S. Food and Drug Administration, or FDA, to report more information on the annual sales of antibiotics used among industrial farm animals. The bipartisan bill would also give the agency a deadline to finalize policies proposed last...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
